Antidepressant prescriptions by provider in patients with kidney failure and depression.

ABSTRACT:

Background

The prevalence of depression is high among patients with end-stage kidney disease (ESKD). Recent studies have indicated under-recognition and -treatment of depression in this population, and little is known about how the specialty of the prescribing clinician may influence clinical outcomes. This study aimed to evaluate whether the prescribing clinician's specialty (psychiatrist vs. non-psychiatrist) is associated with clinical outcomes in patients with ESKD and comorbid depression who receive antidepressant treatment.

Methods

We extracted data from the Korean National Health Institute Database System from January 2004 to December 2022. Patients with ESKD and depression who underwent antidepressant therapy after their ESKD diagnosis were included. Patients were fo

SUBMITTER: Shin DH 

PROVIDER: S-EPMC12813503 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature